A recent Washington Post writer suggested, “CRISPR-Cas9 is arguably this decade’s biggest biotech invention...Its potential is limitless, and so is the amount of money and fame that ownership of the technology would bring to its inventor.”
This free paper explores the intellectual property surrounding the world of CRISPR, the possibilities of widespread applications and the players from a huge cross section of industries that are set to benefit if they invest in the right technologies at the right times.
- What key questions can the CRISPR patent landscape answer?
- Discovering future investment and partnership opportunities
- Tracking funded technologies
